17 Recruiting Studies at Tom Baker Cancer Centre
Active clinical trials at this research center, sourced directly from the NIH registry.
📍 Calgary, Alberta
All research centersRecruiting Studies at Tom Baker Cancer Centre
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Advanced Rare Tumours
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Bladder Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
Breast Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 📋 Clinical Research Protocol
Hypofractionated LocoRegional Radiotherapy in Breast Cancer
Breast Neoplasms
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Economic Analysis of Alliance A041202 CLL Study
Chronic Lymphocytic Leukemia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
Endometrial Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Multiple Myeloma Molecular Monitoring Study
Multiple Myeloma
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
Myelofibrosis
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Ovarian Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
Prostate Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 📋 Clinical Research Protocol
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
Prostate Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
Solid Malignancies
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
Waldenstrom Macroglobulinemia
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Chemoradiotherapy for Advanced Esophageal Cancer
Esophageal Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
Hematologic Neoplasms
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)
Squamous Cell Carcinoma of the Oropharynx
View Study & Checklist ➔